Literature DB >> 3134018

Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties.

C Calvo1, C Talussot, G Ponsin, F Berthézène.   

Abstract

In diabetic patients, hyperglycaemia results in the non enzymatic glycation of many proteins including apolipoprotein A-I. We purified glycated apo A-I and compared its lipid binding properties to those of normal apo A-I. Analysis of tryptophan fluorescence spectra and of fluorescence quenching in the presence of iodine showed that glycation of apo A-I induces a decrease in the stability of the lipid-apoprotein interaction and in that of the apoprotein self-association. Repetitive ultracentrifugations of High Density Lipoprotein (HDL) samples containing radioiodinated apo A-I or glycated apo A-I revealed that glycation of the apoprotein facilitates its dissociation from HDL. These results suggest that the non enzymatic glycation of apo A-I may affect the structural cohesion of HDL particles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134018     DOI: 10.1016/s0006-291x(88)81336-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Effect of the nonenzymatic glycosylation of high density lipoprotein-3 on the cholesterol ester transfer protein activity.

Authors:  B Lemkadem; D Loiseau; G Larcher; Y Malthiery; F Foussard
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

2.  Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.

Authors:  Ju-Yi Hsieh; Chiz-Tzung Chang; Max T Huang; Chia-Ming Chang; Chia-Ying Chen; Ming-Yi Shen; Hsin-Yi Liao; Guei-Jane Wang; Chu-Huang Chen; Chao-Jung Chen; Chao-Yuh Yang
Journal:  Anal Chem       Date:  2013-11-13       Impact factor: 6.986

3.  Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma.

Authors:  Feliciano Priego-Capote; Alexander Scherl; Markus Müller; Patrice Waridel; Frédérique Lisacek; Jean-Charles Sanchez
Journal:  Mol Cell Proteomics       Date:  2009-11-06       Impact factor: 5.911

4.  Semiquantitative analysis of apolipoprotein A-I modified by advanced glycation end products in diabetes mellitus.

Authors:  Yoshifumi Kurosaki; Tomoaki Tsukushi; Shinichi Munekata; Tohru Akahoshi; Tatsumi Moriya; Zensuke Ogawa
Journal:  J Clin Lab Anal       Date:  2013-02-25       Impact factor: 2.352

Review 5.  High-density lipoprotein function, dysfunction, and reverse cholesterol transport.

Authors:  Edward A Fisher; Jonathan E Feig; Bernd Hewing; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12       Impact factor: 8.311

6.  Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects.

Authors:  Kazuhiko Kotani; Naoki Sakane; Masashi Ueda; Shinichi Mashiba; Yasuyuki Hayase; Kokoro Tsuzaki; Toshiyuki Yamada; Alan T Remaley
Journal:  Clin Chim Acta       Date:  2012-09-06       Impact factor: 3.786

Review 7.  Dysfunctional HDL as a diagnostic and therapeutic target.

Authors:  Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-13       Impact factor: 8.311

8.  Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.

Authors:  Sangeeta R Kashyap; Abdullah Osme; Serguei Ilchenko; Makan Golizeh; Kwangwon Lee; Shuhui Wang; James Bena; Stephen F Previs; Jonathan D Smith; Takhar Kasumov
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

Review 9.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

10.  Arginine-directed glycation and decreased HDL plasma concentration and functionality.

Authors:  L Godfrey; N Yamada-Fowler; J Smith; P J Thornalley; N Rabbani
Journal:  Nutr Diabetes       Date:  2014-09-01       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.